Barclays analyst Andrew Mok raised the firm’s price target on Cigna (CI) to $382 from $339 and keeps an Overweight rating on the shares. The firm updated the company’s model post the Q1 report.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Cigna’s Strong Q1 Performance and Growth in Specialty Segments Drive Buy Rating
- Cigna Reports Strong Q1 2025 Results and Raises Outlook
- Cigna’s Earnings Call: Strong Growth and Strategic Innovations
- Morning Movers: Amazon advances, Apple falls following quarterly results
- Options Volatility and Implied Earnings Moves Today, May 02, 2025